06 Dec 2023 --- Pro- and postbiotics producer The Akkermansia Company has secured its place in the weight management nutraceutical space. The US Patent and Trademark Office (USPTO) declared the company’s inventors, Cani et al., as the first to file a patent application related to treating metabolic disorders, particularly obesity, through the oral administration of the probiotic Akkermansia.
